HTLV-1 associated myelopathy/tropical spastic paraparesis
- Human T-cell leukemia virus type 1 associated myelopathy/tropical spastic paraparesis
- Tropical spastic paraparesis (formerly)
News & Events
On this page
ORDR Co-Sponsored Conferences
2016 Rare Disease Day at NIH, Monday, February 29, 2016
Location: Building 10, Masur Auditorium, National Institutes of Health, Bethesda, MD
Description: The 2016 Rare Disease Day at NIH will take place on February 29. The event, sponsored by NCATS and the NIH Clinical Center, aims to raise awareness about rare diseases, the patients they affect and the research collaborations that are addressing rare disease challenges. The day will feature tours, posters and exhibits, and presentations.
15th International Conference on Human Retrovirology: HTLV and Related Viruses, Sunday, June 05, 2011 - Wednesday, June 08, 2011
Location: Leuven, Belgium
Description: The objectives of the 15th Conference on Human Retrovirology: HTLV and Related Viruses in Leuven, Belgium, are to (1) provide a forum for the presentation of original research pertaining to HTLV-I, HTLV-II, and related human viruses; (2) promote interdisciplinary interaction between basic scientists, epidemiologists, and clinical researchers toward fostering bench-to-bedside research; (3) promote interaction between scientists in the developed and developing world and stimulate international collaboration; and (4) expose students and young scientists to the HTLV research arena and promote their research careers so that this new generation may contribute to the field.
Adaptive and Innate Immune Responses to Neglected Tropical Diseases, Sunday, January 10, 2010 - Monday, January 11, 2010
Location: San Diego Airport Hilton Hotel, San Diego, CA
Description: The goals of this workshop were to (1) obtain an update on recent developments in the fields of basic immunology, immune responses to neglected tropical disease (NTD)-causing agents, and pathogenic mechanisms of NTDs; (2) determine what are the knowledge gaps and under-emphasized research areas for certain diseases that may not be receiving particular emphasis and how to stimulate research in these areas; and (3) develop a prioritized future research agenda for these areas. Plans are to publish results in the form of a report that could serve as a guide for donors and sponsors to prepare RFAs and for scientists to refocus their research efforts.